The Treatment Tapes, home

Micronutrients

Omega-3 (EPA/DHA)

Prescription EPA cut cardiac events; the same dose off a shelf has not been shown to.

Filed under Supplement Constellation Micronutrients Status Upcoming

Not yet investigated

What we have so far

Prescription EPA cut cardiac events; the same dose off a shelf has not been shown to.

This star is on the map because the show intends to take the question apart properly — the trials, how it is actually tested, whether the thing sold is the thing studied. That work is not done yet, and nothing here should be read as a conclusion. When the investigation is published it will appear on this page.

What we are reading

Gathered for the investigation and not yet written up. Each note says what the paper does and does not show.

  1. Jia X, Kohli P, Virani SS. Omega-3 fatty acid and cardiovascular outcomes: insights from recent clinical trials.Curr Atheroscler Rep · 2019 · 21(1):110.1007/s11883-019-0763-0 · PMID 30631963

    Why 'fish oil' is not one question. Reading REDUCE-IT alongside ASCEND and VITAL, the authors conclude the benefit tracks FORMULATION and DOSE: high-dose PURE eicosapentaenoic acid reduced atherosclerotic events where mixed EPA/DHA preparations at ordinary doses did not. A trial of a 4 g pure-EPA prescription drug says nothing about a 1 g supermarket capsule, and both get reported as 'omega-3'.

Connected on the map

Back to the constellation map

The letter

Every source, in your inbox.

The full citation list for each investigation, the studies that didn't make the episode, and any corrections — sent the morning it publishes.

No sponsors · No supplement affiliates · Unsubscribe any time